- Volume is elevated versus the 13-week average, confirming attention.
VTX
ASX
Week ended 07 Aug 2026
Weekly Investor Report
Vertex Minerals Limited · Basic Materials · Gold
Latest close
0.14 AUD
54.3%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -7.4% below the Trend Line and sits at 16.9% of its 52-week range. The latest completed week returned 54.3%, after a 45.0% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 51/100.
Setup score
37
out of 100
Latest Close
0.14 AUD
7 Aug 2026
1W Return
54.3%
latest completed week
4W Return
45.0%
short-term follow-through
12W Return
0.0%
quarterly tape
Trend Breadth
13.5%
7 of 52 weeks active
Volume Ratio
2.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
54.3%
Latest completed week; four-week move 45.0%.
Indicator stack
7/40
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.93%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
51/100
20 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -7.4% below the Trend Line and sits at 16.9% of its 52-week range. The latest completed week returned 54.3%, after a 45.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.4x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0112-week average 0.02
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 45.0% over four weeks, 0.0% over 12 weeks, and -29.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year7
Trend breadth13.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.74Latest activity-pressure read.
Pressure change45.0%Four-week change in activity pressure.
Leadership-32.71Latest relative-leadership reading.
RS change38.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 30 Jun 2024
Field coverage 52%
Model confidence 15%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength8/100Blend of value, momentum, and quality. Underlying universe rank 93; rank 1 is best.
Value22/100Relative valuation strength. Underlying universe rank 79; rank 1 is best.
Quality20/100Profitability and accounting quality. Underlying universe rank 81; rank 1 is best.
Momentum21/100Medium-term price momentum. Underlying universe rank 80; rank 1 is best.
Growth22/100Revenue and earnings growth. Underlying universe rank 79; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- - Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -10.4% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- - Operating profit retained from revenue.
- Free-cash-flow margin
- - Free cash flow generated from revenue.
- Return on invested capital
- -8.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- - Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 2/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -11.5% Net share repurchases relative to market value.
- Shareholder yield
- -11.5% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.6x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 20 relevant articles.
1 positive · 19 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-64.2%Distance below the 52-week high.
13-week volatility16.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher9 of 2614 weeks finished lower.
Best week+54.3%Week of 7 Aug.
Worst week-21.4%Week of 6 Mar.
Latest week+54.3%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains2
Flat weeks3
Modest losses4
Sharp losses10
Recent vol16.7%13-week weekly-return volatility.
Base vol13.0%52-week weekly-return volatility.
Up/down split20/27Count of positive and negative weeks in the 52-week window.
Average skew12.5% / -9.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorAU Basic Materials
4-week rank- / 100
Group average7.2%
Trend breadth21.0%
Trend21.0%active weekly trend signals
MD27.0%positive activity pressure
RS52.0%positive relative leadership
Four-week leaders
IndustryAU Gold
4-week rank2 / 100
Group average5.5%
Trend breadth6.0%
Trend6.0%active weekly trend signals
MD17.0%positive activity pressure
RS30.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape25/100
Trend, activity pressure, participation, and risk combine to a 25/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 41.93%Next-week expectancy is negative with a 41.93% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors16/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 84; Small Cap Core rank 75 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment51/100Weighted news tone is neutral across 20 relevant articles.
Vertex Pharmaceuticals (VRTX) Q2 Earnings Report Preview: What To Look For Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.14 AUD | 54.3% | 0.16 AUD | 0.18 AUD | -0.74 | -32.71 | 3.6M | Off |
| 31 Jul 2026 | 0.09 AUD | -1.1% | 0.16 AUD | 0.18 AUD | -1.49 | -55.26 | 1.8M | Off |
| 24 Jul 2026 | 0.10 AUD | -3.1% | 0.16 AUD | 0.18 AUD | -1.53 | -54.25 | 1.7M | Off |
| 17 Jul 2026 | 0.10 AUD | -2.0% | 0.17 AUD | 0.18 AUD | -1.39 | -53.45 | 1.2M | Off |
| 10 Jul 2026 | 0.10 AUD | -4.8% | 0.17 AUD | 0.18 AUD | -1.35 | -53.12 | 680.3K | Off |
| 3 Jul 2026 | 0.10 AUD | -8.7% | 0.18 AUD | 0.18 AUD | -1.27 | -51.60 | 343.9K | Off |
| 26 Jun 2026 | 0.12 AUD | 4.5% | 0.18 AUD | 0.18 AUD | -1.22 | -47.24 | 601.5K | Off |
| 19 Jun 2026 | 0.11 AUD | 4.8% | 0.19 AUD | 0.18 AUD | -1.18 | -50.61 | 998.2K | Off |
| 12 Jun 2026 | 0.10 AUD | -12.5% | 0.19 AUD | 0.18 AUD | -1.00 | -53.37 | 1.4M | Off |
| 5 Jun 2026 | 0.12 AUD | -7.7% | 0.20 AUD | 0.18 AUD | -0.80 | -46.54 | 379.1K | Off |
| 29 May 2026 | 0.13 AUD | -10.3% | 0.20 AUD | 0.18 AUD | -0.63 | -43.82 | 1.2M | Off |
| 22 May 2026 | 0.14 AUD | 0.0% | 0.20 AUD | 0.18 AUD | -0.74 | -37.41 | 1.6M | Off |
| 15 May 2026 | 0.14 AUD | -14.7% | 0.21 AUD | 0.18 AUD | -0.83 | -37.78 | 4.2M | Off |
| 8 May 2026 | 0.17 AUD | 3.0% | 0.21 AUD | 0.18 AUD | -0.91 | -28.70 | 1.5M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.